147 related articles for article (PubMed ID: 36207724)
21. Transforming vaccines supply chains in Nigeria.
Sarley D; Mahmud M; Idris J; Osunkiyesi M; Dibosa-Osadolor O; Okebukola P; Wiwa O
Vaccine; 2017 Apr; 35(17):2167-2174. PubMed ID: 28364926
[TBL] [Abstract][Full Text] [Related]
22. Country-level governance of global health initiatives: an evaluation of immunization coordination mechanisms in five countries of Asia.
Grundy J
Health Policy Plan; 2010 May; 25(3):186-96. PubMed ID: 19926659
[TBL] [Abstract][Full Text] [Related]
23. Strategic donor behaviour and country vulnerability in health aid transitions.
Mao W; McDade KK; Ogbuoji O; Yamey G; Bermeo SB
BMJ Glob Health; 2023 Nov; 8(11):. PubMed ID: 37940202
[TBL] [Abstract][Full Text] [Related]
24. Improving cold chain systems: Challenges and solutions.
Ashok A; Brison M; LeTallec Y
Vaccine; 2017 Apr; 35(17):2217-2223. PubMed ID: 27670076
[TBL] [Abstract][Full Text] [Related]
25. Designing supply chains to meet the growing need of vaccines: evidence from four countries.
Prosser W; Spisak C; Hatch B; McCord J; Tien M; Roche G
J Pharm Policy Pract; 2021 Sep; 14(1):80. PubMed ID: 34587993
[TBL] [Abstract][Full Text] [Related]
26. Assessment of vaccination service delivery and quality: a cross-sectional survey of over 1300 health facilities from 29 districts in Sindh, Pakistan conducted between 2017-18.
Siddiqi DA; Abdullah S; Dharma VK; Khamisani T; Shah MT; Setayesh H; Khan AJ; Chandir S
BMC Health Serv Res; 2022 Jun; 22(1):727. PubMed ID: 35650570
[TBL] [Abstract][Full Text] [Related]
27. Transforming cold chain performance and management in lower-income countries.
Brison M; LeTallec Y
Vaccine; 2017 Apr; 35(17):2107-2109. PubMed ID: 28364916
[TBL] [Abstract][Full Text] [Related]
28. COVID-19 Vaccine Collaborative Supply Planning: Is This the Next Frontier for Routine Immunization Supply Chains?
Akhlaghi L; Prosser W; Rakotomanga A; Makena J; Azubike T; Bello Y; Emelike S; Mothetsi L; Motuba M; Olayemi V; Samba S; Suh S; Ramaroson S; Yarro FDN
Glob Health Sci Pract; 2024 Feb; 12(Suppl 1):. PubMed ID: 38378271
[TBL] [Abstract][Full Text] [Related]
29. Two decades of vaccine innovations for global public good: Report of the Developing Countries' Vaccine Manufacturers Network 20th meeting, 21-23 october 2019, Rio de Janeiro, Brazil.
Pagliusi S; Dennehy M; Homma A
Vaccine; 2020 Aug; 38(36):5851-5860. PubMed ID: 32535016
[TBL] [Abstract][Full Text] [Related]
30. New vaccine adoption: qualitative study of national decision-making processes in seven low- and middle-income countries.
Burchett HE; Mounier-Jack S; Griffiths UK; Biellik R; Ongolo-Zogo P; Chavez E; Sarma H; Uddin J; Konate M; Kitaw Y; Molla M; Wakasiaka S; Gilson L; Mills A
Health Policy Plan; 2012 May; 27 Suppl 2():ii5-16. PubMed ID: 22513732
[TBL] [Abstract][Full Text] [Related]
31. GAVI and the Vaccine Fund--a boon for immunization in the developing world.
Balaji KA
Indian J Public Health; 2004; 48(2):45-8. PubMed ID: 15709583
[TBL] [Abstract][Full Text] [Related]
32. Effect of donor funding for immunization from Gavi and other development assistance channels on vaccine coverage: Evidence from 120 low and middle income recipient countries.
Ikilezi G; Augusto OJ; Dieleman JL; Sherr K; Lim SS
Vaccine; 2020 Jan; 38(3):588-596. PubMed ID: 31679863
[TBL] [Abstract][Full Text] [Related]
33. Costs of introducing and delivering HPV vaccines in low and lower middle income countries: inputs for GAVI policy on introduction grant support to countries.
Levin A; Wang SA; Levin C; Tsu V; Hutubessy R
PLoS One; 2014; 9(6):e101114. PubMed ID: 24968002
[TBL] [Abstract][Full Text] [Related]
34. Optimized supply chain model reduces health system costs in DRC.
Thomas D; Motomoke E; Crawford J; Defawe O; Makaya A; Ngwato JW; Bompongo J; Monzembela J; Ailstock G; Bancroft E; Magadzire B; Baabo D; Watson N
Vaccine; 2021 Jul; 39(30):4166-4172. PubMed ID: 34127290
[TBL] [Abstract][Full Text] [Related]
35. A global health partnership's use of time-limited support to catalyze health practice change: the case of GAVI's Injection Safety Support.
Levin A; Fang A; Hansen PM; Pyle D; Dia O; Schwalbe N
PLoS One; 2010 Sep; 5(9):e12986. PubMed ID: 20885995
[TBL] [Abstract][Full Text] [Related]
36. Visibility and Analytics Network (VAN) approach to improve immunization supply chain and management performance system in Pakistan.
Altaf A; Siddiqui A; Ashfaq AM; Shahabuddin A
J Glob Health; 2021 Mar; 11():06002. PubMed ID: 33791097
[TBL] [Abstract][Full Text] [Related]
37. Role of Global Alliance for Vaccines and Immunization (GAVI) in Accelerating Inactivated Polio Vaccine Introduction.
Thacker N; Thacker D; Pathak A
Indian Pediatr; 2016 Aug; 53 Suppl 1():S57-S60. PubMed ID: 27771641
[TBL] [Abstract][Full Text] [Related]
38. Gavi's policy steers country ownership and self-financing of immunization.
Henderson K; Gouglas D; Craw L
Vaccine; 2016 Aug; 34(37):4354-9. PubMed ID: 27431423
[TBL] [Abstract][Full Text] [Related]
39. Introducing new vaccines in the poorest countries: what did we learn from the GAVI experience with financial sustainability?
Lydon P; Levine R; Makinen M; Brenzel L; Mitchell V; Milstien JB; Kamara L; Landry S
Vaccine; 2008 Dec; 26(51):6706-16. PubMed ID: 18952134
[TBL] [Abstract][Full Text] [Related]
40. Lessons learned in shaping vaccine markets in low-income countries: a review of the vaccine market segment supported by the GAVI Alliance.
Gilchrist SA; Nanni A
Health Policy Plan; 2013 Dec; 28(8):838-46. PubMed ID: 23174880
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
